Medicare Enrolled
Dr. Erick Green, MD
Sports Medicine (Family Medicine) Physician · Clovis, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Green from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Green?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Green
Dr. Erick Green is a sports medicine physician in Clovis, CA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Green performed 2,495 Medicare services across 1,903 unique beneficiaries.
Between the years covered by Open Payments, Dr. Green received a total of $2,057 from 22 pharmaceutical and/or device companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in sports medicine (family medicine) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Green is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 20% volume in CA
$2,057 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,495
Medicare services
Top 20% in CA for sports medicine (family medicine) physician
1,903
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~178 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
418 | $63 | $150 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
339 | $76 | $200 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
252 | $0 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
196 | $11 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
191 | $96 | $170 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
163 | $2 | $15 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
136 | $35 | $120 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
136 | $16 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
125 | $115 | $250 |
| Strep A rapid test A rapid test to detect Group A Streptococcus bacteria using an immunoassay method with direct visual observation. |
97 | $16 | $40 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
82 | $1 | $35 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
60 | $0 | $5 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
51 | $30 | $40 |
| Inhalation treatment for airway obstruction or sputum production A treatment involving the inhalation of medication to help clear airway obstructions or reduce sputum production. |
46 | $7 | $50 |
| Albuterol inhalation solution, 1 mg A unit dose of FDA-approved albuterol solution administered via durable medical equipment for inhalation. |
36 | $0 | $10 |
| Inhaled ipratropium bromide, unit dose Administration of FDA-approved ipratropium bromide inhalation solution via durable medical equipment in a unit dose form. |
36 | $0 | $10 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
35 | $0 | $20 |
| Ear wax removal by washing This procedure involves the removal of impacted ear wax using a washing technique. |
30 | $13 | $20 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
15 | $27 | $60 |
| Haemophilus influenzae antibody test A blood test that measures the level of antibodies to the Haemophilus influenzae bacteria. This analysis helps determine if the body has developed an immune response to this respiratory bacteria. |
13 | $16 | $20 |
| Mycoplasma pneumoniae nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of Mycoplasma pneumoniae bacteria. |
13 | $34 | $40 |
| Levalbuterol inhalation solution, 0.5 mg A 0.5 mg dose of levalbuterol inhalation solution administered through durable medical equipment. This is a non-compounded, FDA-approved concentrated form of the medication. |
13 | $0 | $20 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
12 | $9 | $70 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.4% high complexity
22.6% medium
74.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,057
Total received (2018-2024)
Avg $294/year across 7 years
Top 19% in CA for sports medicine (family medicine) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
22
Companies
74
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,057 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$327
2023
$256
2022
$56
2021
$120
2020
$86
2019
$318
2018
$895
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$185
GlaxoSmithKline, LLC.
$121
Ultragenyx Pharmaceutical Inc.
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$581
Boehringer Ingelheim Pharmaceuticals, Inc.
$293
AstraZeneca Pharmaceuticals LP
$260
Genentech USA, Inc.
$163
Octapharma USA, Inc.
$131
ALK-Abello, Inc
$125
Circassia Pharmaceuticals Inc
$125
CSL Behring
$43
Shire North American Group Inc
$42
Kaleo, Inc.
$39
Teva Pharmaceuticals USA, Inc.
$35
Optinose US, Inc.
$24
Amgen Inc.
$24
GENZYME CORPORATION
$22
BioCryst US Sales Co., LLC
$21
Kowa Pharmaceuticals America, Inc.
$21
Ultragenyx Pharmaceutical Inc.
$20
Regeneron Healthcare Solutions, Inc.
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
Mylan Specialty L.P.
$19
Bioventus LLC
$16
Nabriva Therapeutics, plc
$14
Top 3 companies account for 55.1% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · AUVI-Q · AirDuo Digihaler · Auvi-Q · BREO · CUVITRU · Crysvita · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Durolane · Dymista · FASENRA · Haegarda · Livalo · NIOX VERO · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Orladeyo · ProAir Digihaler · SPIRIVA RESPIMAT · SYMBICORT · TAKHZYRO · TRELEGY ELLIPTA · Xenleta · Xhance · Xofluza · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Sports medicine physicians within 10 mi
7
Per 100K population
0.7
County median income
$71,434
Nearest hospital
CLOVIS COMMUNITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Green is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement in the top 19% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Green experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Green performed 418 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Green receive payments from pharmaceutical companies?
Yes. Dr. Green received a total of $2,057 from 22 companies across 74 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Green's costs compare to other sports medicine physicians in Clovis?
Dr. Green's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Green) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Sports Medicine Physicians in Clovis
Browse sports medicine physicians in Clovis ranked by procedure volume and transparency data.
Highest volume
Top Sports Medicine Physicians in CA
Sports medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Sports Medicine Physicians in CA
Which CA sports medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology